Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2021-05-07 Purchase |
2021-05-11 08:58 am |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
23,250 | $8.6018 | $199,992 | 131,802 (Direct) |
View |
| 2021-05-06 Purchase |
2021-05-10 7:57 pm |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
4,000 | $7.82 | $31,280 | 4,000 (Direct) |
View |
| 2021-03-18 Sale |
2021-03-23 07:50 am |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
4,000 | $12.39 | $49,553 | 1,634,978 (Indirect Direct) |
View |
| 2021-03-18 Sale |
2021-03-23 07:48 am |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
4,000 | $12.39 | $49,553 | 1,634,978 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:12 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,186 | $14.83 | $17,590 | 51,791 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:11 pm |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
2,887 | $14.83 | $42,818 | 46,126 (Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:10 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
18,990 | $14.83 | $281,644 | 1,351,578 (Indirect Direct) |
View |
| 2021-02-18 Sale |
2021-02-22 8:09 pm |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
18,990 | $14.83 | $281,644 | 1,351,578 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:49 pm |
Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs |
2,046 | $15.52 | $31,752 | 4,143 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:48 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,748 | $15.52 | $27,127 | 62,677 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:47 pm |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
2,046 | $15.52 | $31,752 | 68,363 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:46 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael SVP, CFO & Treasurer |
2,858 | $15.52 | $44,354 | 5,292 (Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:45 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
13,243 | $15.52 | $205,518 | 1,457,768 (Indirect Direct) |
View |
| 2021-02-11 Sale |
2021-02-17 6:44 pm |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
13,243 | $15.52 | $205,518 | 1,457,768 (Indirect Direct) |
View |
| 2020-12-18 Sale |
2020-12-22 6:16 pm |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
5,000 | $18 | $90,000 | 0 (Direct) |
View |
| 2020-12-07 Sale |
2020-12-08 5:14 pm |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
20,000 | $16.07 | $321,383 | 5,000 (Direct) |
View |
| 2020-12-01 Sale |
2020-12-03 5:17 pm |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
137,061 | $17.53 | $2,402,227 | 68,241 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2021-05-21 Option Award |
2021-05-21 5:35 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:35 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:34 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:33 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:32 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | Dolsten Mikael Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:31 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-03 Option Award |
2021-05-04 9:06 pm |
N/A 2031-05-02 |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
933,000 | $0 | 933,000 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:17 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
81,981 | $0 | 167,659 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:16 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael SVP, CFO & Treasurer |
81,981 | $0 | 111,723 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:13 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs |
81,981 | $0 | 105,369 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:12 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
81,981 | $0 | 164,407 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:10 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | DEMAREE JOHN Chief Commercial Officer |
59,026 | $0 | 67,172 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:09 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
364,200 | $0 | 1,945,978 (Direct) |
View |
| 2021-02-25 Option Award |
2021-03-01 8:09 pm |
N/A 2031-02-24 |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
364,200 | $0 | 1,945,978 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:48 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
4,850 | $0 | 62,677 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:47 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
9,675 | $0 | 68,363 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:45 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
43,600 | $0 | 1,457,768 (Direct) |
View |
| 2021-02-15 Exercise |
2021-02-17 6:44 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
43,600 | $0 | 1,457,768 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 9:56 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
5,650 | $0 | 66,825 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:34 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Lewis Tanya EVP, Chief Reg. Affairs |
5,650 | $0 | 23,139 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:33 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
5,650 | $0 | 58,334 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:32 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael SVP, CFO & Treasurer |
8,150 | $0 | 32,600 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:30 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon President & CSO |
28,600 | $0 | 1,426,011 (Direct) |
View |
| 2021-02-05 Exercise |
2021-02-09 8:28 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Chief Executive Officer |
28,600 | $0 | 1,426,011 (Direct) |
View |
Ownership |
2021-01-05 7:39 pm |
N/A 2030-11-29 |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
0 | $0 | 103,000 (Direct) |
View |
Ownership |
2021-01-05 7:33 pm |
N/A 2030-12-13 |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
0 | $0 | 100,000 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 6:16 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
5,000 | $5.43 | 0 (Direct) |
View |
| 2020-12-18 Exercise |
2020-12-22 6:16 pm |
N/A 2029-06-05 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
5,000 | $0 | 0 (Direct) |
View |
| 2020-12-07 Exercise |
2020-12-08 5:14 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
20,000 | $5.43 | 5,000 (Direct) |
View |
| 2020-12-07 Exercise |
2020-12-08 5:14 pm |
N/A 2029-06-05 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
20,000 | $0 | 5,000 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A 2028-01-23 |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
137,061 | $0 | 68,241 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
58,937 | $10.39 | 68,241 (Direct) |
View |
| 2020-12-01 Exercise |
2020-12-03 5:17 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Primiano Christopher Brett EVP, CBO, GC & Secretary |
78,124 | $10.45 | 68,241 (Direct) |
View |
| 2020-11-25 Option Award |
2020-11-30 4:17 pm |
N/A 2030-11-24 |
Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director |
32,800 | $0 | 32,800 (Direct) |
View |